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tween genetic markers and cerebrospinal fluid protein levels was assessed us-
ing linear regression after adjustment for age, gender and the principle
components fromEigenSoft analysis. Analysis was performed in each sample
independently; results were combined in a metaanalysis using METAL. We
applied additional filters to find a set of associated markers that are the highest
priority for follow-up. SNPs from these loci were tested for association with
AD status in data from the Alzheimer’s Disease Genetics Consortium.
Results: 69 phenotypes were analyzed after QC filtering. We 12 identified
candidate loci for 11 phenotypes including cis-effects for Angiotensin Con-
verting Enzyme (rs4968782 P¼3E-12), Interleukin 6 Receptor (rs61812598
P¼5E-63) and Matrix Metalloproteinase 3 (rs679620 P¼5E-44) and trans ef-
fects for CD-40 antigen (rs7250371 P¼7E-09), Chemokine CC-4 (P¼8E-22;
P¼5E-09), Macrophage Inflammatory Protein-1 beta (rs6808835 P¼1E-13),
Monocyte Chemotactic Protein 1 (rs2228467 P¼3E-18), Osteopontin
(rs11076196 P¼2E-08), Prostatic Acid Phosphatase (rs3844501 P¼2E-23),
Sortilin (rs1708487 P¼3E-09) and Trefoil Factor 3 (rs7280100 P¼1E-08).
Of these loci, SNPs in ACE (p¼0.003), MMP3 (p¼0.01) and PAP (0.03)
showed association with AD risk. Conclusions: We have identified 12 loci
with strong and replicable genetic associations with levels of 11 different pro-
teins in the cerebrospinal fluid. Associations with AD status for ACE, MMP3
and PAP indicate a possible role for these markers in AD risk. These findings
illustrate the utility of an endophenotype based approach to understanding
disease risk and identify these genes and important therapeutic targets for
modulating risk for AD and other disorders related to these proteins.
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Background:Variantswithin a 50 haplotypeof the sortilin-related receptor, L-
class, A repeat-containing (SORL1) gene have been repeatedly implicated in
late-onset AD. To characterize risk posed by these variants across the lifespan,
we analyzed their effects on1)whitematter integrityusing diffusion tensor im-
aging (DTI), 2) prefrontal SORL1 mRNA levels, and 3) postmortem amyloid
plaque and tau tangle pathology. Methods: Imaging-genetics analysis was
performed on two samples: 118 healthy subjects (CAMH, age 18-86) on
a 1.5T GE scanner with 23 directions, and 68 healthy Caucasian subjects
(Zucker Hillside, age 8-40) on a 3T GE scanner, with 31 directions. TBSS
was used to assess the effect of genotypic group on voxel-wise fractional an-
isotropy (FA), co-varying for age, sex, and APOE-ε4 status where possible.
Prefrontal SORL1 mRNA was quantified in the BrainCloud dataset (access
through dbGaP, NCBI, n¼269) using Illumina microarrays. Immunohisto-
chemical analysis was performed on a sample of postmortem Caucasian
HC, MCI, and AD brains (Rush University Memory and Aging Project/Reli-
gious Orders Study, Chicago, Il, USA: n¼782) to quantify amyloid plaque
and paired helical filament-tau separately for mesial temporal and neocortical
structures. All samples were genotyped for risk SNPs within the SORL1 50
haplotype. Results: rs689021 was associated with reductions in fronto-tem-
poral WM FA in both the CAMH and Zucker Hillside samples, at a 5%
FWE corrected threshold (See Figure). The effects were independent of
age, manifesting as early as childhood and adolescence. In BrainCloud, the
rs689021 risk genotype significantly predicted a period of reduced gene ex-
pression in Caucasians during adolescence (F¼7.03, p¼0.0003). Postmortem
pathology analysis revealed associations of rs668387 with amyloid plaques in
thewhole sample (t¼4.84, p¼0.028) and neocortical tangles in healthy subsetonly (t¼9.03, p¼0.0027). Conclusions: Our results suggest that 1) variation
in the SORL1 gene may confer risk for AD via temporo-frontal WM circuitry
long before the onset of AD symptoms, 2) SORL1 variation predicts a dy-
namic period of mRNA expression during development, and 3) SORL1 ge-
netic risk may stem from altered amyloid plaque and tau tangle pathology
in the whole brain and neocortex, respectively.
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Background: To leverage genome-wide data from several cohorts so as to
identify genetic determinants of age-related cognitive decline among olderAf-
rican-American (AA) people.Methods:We examined genome-wide genotyp-
ing data for 4,426 unrelated older AA subjects who had at least two repeated
measures of cognition from six (CHAP, IIDP, ROS, MAP, MARS, and WHI-
CAP) prospective community-based studies. We compared them to 2,703 un-
related non-Hispanic European Americans (EAs) from the ROS, MAP and
CHAP studies. Within each cohort, individual cognitive tests were combined
to form an aggregate measure of global cognition. We used linear mixed ef-
fects models to characterize individual paths of change in cognition, control-
ling for age, sex and education as fixed effects. After quality control,
imputation was performed using the 1000 Genomes Project Phase I combined
reference panels of EA and AA ancestry. Common variants were meta-ana-
lyzed across cohorts using weighted fixed-effect models. HAPMIX software
was used to estimate ancestry at each locus, and MIXSCORE software was
used to test whether individuals with faster or slower rates of global cognitive
decline had a proportion of ancestry different from the genome average.
Results: APOE ε4 haplotype was strongly associated with rate of cognitive
decline in AAs (P¼ 1.92 x 10 -14) but the magnitude of the effect was weaker
in AAs (b¼ -0.01) compared to EAs (b¼ -0.05). In AAs we replicated previ-
ously known loci in EAs including ABCA7 (P¼ 4.13 x 10 -4), PICALM (7.35
x 10 -4), and EPHA1 (P¼ 8.06 x 10 -4).We discovered one genome-wide sig-
nificant association at the TRPS1 locus (chr 8q23), and replicated that associ-
ation in EAs (P(DISC) ¼ 2.52 x 10 -7; P(REP) ¼ 9.79 x 10 -3; P(JOINT) ¼
1.37 x 10 -8). We also found another variant at the TEK locus (chr 9p21) with
suggestive evidence of association (P(DISC)¼ 4.10 x 10 -7). Using admixture
mapping, we did not detect any significant admixture peak. Conclusions:
These results suggest that genetic factors alone may not explain differences
Oral Sessions: O4-01: Basic Science: Genetics II—Alzheimer’s Disease–Associated Endophenotypes P679in age-related cognitive decline between AAs and EAs. Further large-scale
admixture mapping studies will be necessary to validate our findings.
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Background:Human episodicmemory is a complex trait with substantial es-
timated heritability (30-60%) (Pappassotiropoulos et al. TICS 2011). How-
ever, the factors impacting memory in cognitive aging and in dementia are., “Predictors of memory performance in a large stratified random p
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cterizing APOE ε2/ε3/ε4 alleles (rs429358, rs7412) were not genonotwell-characterized.Using theHealth andRetirement Study (HRS), a large,
population-based sample of older Americans (N¼16,261), we aimed to iden-
tify variables predictive of memory performance, assess candidate memory
genes for replication of association, and use an unbiased genome-wide ap-
proach (GWAS) to discover additional genes and pathways related tomemory.
Methods: Cross-sectional data fromHRSwave 3 was analyzed. Stepwise lin-
ear regressionwas performed using recall on a 10-word list learning task as the
outcome and variables indicating demographic, cognitive, health, behavioral,
occupational, socioeconomic, and marital status as potential predictors. SNP
genotypes (Illumina HumanOmni2.5 array) passing standard quality control
including 1% minor allele frequency were tested for association to memory
score usingPLINK (N¼6,695). Post-GWASpathway analysis was performed
using GATES/GSA-SNP. Independent replication samples included the Reli-
gious Orders Study/Rush Memory and Aging Project (ROS/MAP) and Alz-
heimer’s Disease Neuroimaging Initiative (ADNI) datasets. Results:
Immediate and delayed recall were highly correlated (r¼0.79) and explained
by identical predictor variables. The 13 variables significantly associated with
immediate recall accounted for 36% of its variance (See Table). Controllingopulation sample of older Americans: clinical, demographic, lifestyle, and
y recall on a 10-word list learning task (N¼16,261)
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